Standards of care for treatment of recurrent glioblastoma—are we there yet?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 15, Issue 1, Pages 4-27
Publisher
Oxford University Press (OUP)
Online
2012-11-08
DOI
10.1093/neuonc/nos273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
- (2017) Sith Sathornsumetee et al. NEURO-ONCOLOGY
- Role of Mismatch Repair and MGMT in Response to Anticancer Therapies
- (2012) Ida Casorelli et al. Anti-Cancer Agents in Medicinal Chemistry
- Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?
- (2012) Katharina Seystahl et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Current concepts and management of glioblastoma
- (2011) Matthias Preusser et al. ANNALS OF NEUROLOGY
- Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy
- (2011) David A. Reardon et al. CANCER
- Bevacizumab and daily temozolomide for recurrent glioblastoma
- (2011) Annick Desjardins et al. CANCER
- Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme
- (2011) J. C. Easaw et al. Current Oncology
- Evolution of care for patients with relapsed glioblastoma
- (2011) Carmen Balañá et al. Expert Review of Anticancer Therapy
- 2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies
- (2011) Manmeet S Ahluwalia Expert Review of Anticancer Therapy
- Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
- (2011) Jörg Felsberg et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study
- (2011) John F. de Groot et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients
- (2011) Paola Gaviani et al. JOURNAL OF NEURO-ONCOLOGY
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
- (2011) Mark R. Gilbert et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma
- (2011) D.-S. Kong et al. NEURO-ONCOLOGY
- Clinical trial end points for high-grade glioma: the evolving landscape
- (2011) D. A. Reardon et al. NEURO-ONCOLOGY
- Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches
- (2011) Kathryn Beal et al. Radiation Oncology
- Understanding Glioblastoma Tumor Biology: The Potential to Improve Current Diagnosis and Treatments
- (2011) Santosh Kesari SEMINARS IN ONCOLOGY
- Neuroradiological Response Criteria for High-grade Gliomas
- (2011) K. Lutz et al. Clinical Neuroradiology
- Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
- (2010) J. J. C. Verhoeff et al. ANNALS OF ONCOLOGY
- BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
- (2010) Thomas Reithmeier et al. BMC CANCER
- A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas
- (2010) Jeffrey J. Raizer et al. CANCER
- Dose-dense temozolomide regimens
- (2010) Bart Neyns et al. CANCER
- American Society of Clinical Oncology 2010: report of selected studies from the CNS tumors section
- (2010) Patrick Y Wen Expert Review of Anticancer Therapy
- Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?
- (2010) Michael Weller et al. Future Oncology
- Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme
- (2010) Alessandra B. Francesconi et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
- (2010) Michael Brada et al. JOURNAL OF CLINICAL ONCOLOGY
- Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
- (2010) John K. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- (2010) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma
- (2010) Florian Stockhammer et al. JOURNAL OF NEURO-ONCOLOGY
- Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma
- (2010) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
- (2010) Tobias Walbert et al. JOURNAL OF NEURO-ONCOLOGY
- A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
- (2010) Raffaele Addeo et al. JOURNAL OF NEURO-ONCOLOGY
- Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme
- (2009) M D Groves et al. BRITISH JOURNAL OF CANCER
- Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
- (2009) D A Reardon et al. BRITISH JOURNAL OF CANCER
- Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation
- (2009) Philippe Metellus et al. CANCER
- Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
- (2009) Alba A. Brandes et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas
- (2009) Philip H. Gutin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage therapy with single agent bevacizumab for recurrent glioblastoma
- (2009) Marc C. Chamberlain et al. JOURNAL OF NEURO-ONCOLOGY
- Extended-schedule dose-dense temozolomide in refractory gliomas
- (2009) A. Berrocal et al. JOURNAL OF NEURO-ONCOLOGY
- Rechallenge with temozolomide in patients with recurrent gliomas
- (2009) Antje Wick et al. JOURNAL OF NEUROLOGY
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- Bevacizumab and chemotherapy for recurrent glioblastoma: A single-institution experience
- (2009) P. L. Nghiemphu et al. NEUROLOGY
- Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience
- (2008) Silvia Scoccianti et al. ANTI-CANCER DRUGS
- ‘Recurrent’ glioblastoma multiforme, when should we reoperate?
- (2008) Giuseppe M. V. Barbagallo et al. BRITISH JOURNAL OF NEUROSURGERY
- Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
- (2008) Casilda Balmaceda et al. CANCER
- Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
- (2008) Walter Taal et al. CANCER
- MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma
- (2008) J. Sadones et al. EUROPEAN JOURNAL OF CANCER
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
- MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
- (2008) Alba A. Brandes et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in Glioma
- (2008) Ilse Vlassenbroeck et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- ACNU-based chemotherapy for recurrent glioma in the temozolomide era
- (2008) Caroline Happold et al. JOURNAL OF NEURO-ONCOLOGY
- Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?
- (2008) Amerigo Boiardi et al. JOURNAL OF NEURO-ONCOLOGY
- A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma
- (2008) Maria Grazia Fabrini et al. JOURNAL OF NEURO-ONCOLOGY
- Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival
- (2008) Ashwatha Narayana et al. JOURNAL OF NEUROSURGERY
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
- (2008) Dieta Brandsma et al. LANCET ONCOLOGY
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- A novel tool to analyze MRI recurrence patterns in glioblastoma
- (2008) Wolfgang Wick et al. NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now